Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and ...
In SYNCHRONIZE-1, survodutide achieved −12.2% to −13.0% weight loss at 76 weeks versus −5.4% with placebo, with ≥20% loss in 28.5% at 6.0 mg. MRI substudy data showed organ-selective effects: liver ...
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The new Philips Smart Lighting entertainment setup Signify has taken the covers off a new ...
In Guangdong, China, on Monday, May 4, 2026, a video shared by user @Huáiyàtèya captured a moment of canine camaraderie that has sparked laughter on social media Trump has exacted revenge on GOP ...
From weather forecasting to next-token prediction, modern machine learning models have shown striking success at predicting a complex, dynamical world. Across this variety, I argue that two ...
Scientists at the University of Colorado Boulder have discovered something that experienced ballroom dancers have long known: When dancers are in tune with each other, their brains may sync up, ...
But when I saw an inexpensive “for parts only” second-generation Sync Module available for sale on eBay, I still jumped on the opportunity, driven by curiosity. Primary differences between the two ...
Today, I’d like to share a simple but common scenario of MySQL-to-MySQL data synchronization and merging. This case reflects a problem I encountered in real work, and I hope it can spark discussion. I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results